Griffin M Weber, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 19 | 2023 | 4775 | 1.390 |
Why?
|
| Information Storage and Retrieval | 9 | 2024 | 822 | 1.120 |
Why?
|
| Computer Communication Networks | 3 | 2014 | 294 | 0.810 |
Why?
|
| Cell Biology | 2 | 2021 | 90 | 0.750 |
Why?
|
| Medical Record Linkage | 3 | 2021 | 288 | 0.710 |
Why?
|
| Cells | 1 | 2021 | 164 | 0.710 |
Why?
|
| Atlases as Topic | 1 | 2021 | 241 | 0.710 |
Why?
|
| Software | 8 | 2024 | 4419 | 0.560 |
Why?
|
| Biomedical Research | 10 | 2024 | 3426 | 0.540 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2018 | 749 | 0.490 |
Why?
|
| Search Engine | 2 | 2015 | 140 | 0.480 |
Why?
|
| Algorithms | 13 | 2023 | 13981 | 0.440 |
Why?
|
| Cell Lineage | 2 | 2021 | 2533 | 0.420 |
Why?
|
| Privacy | 4 | 2022 | 233 | 0.400 |
Why?
|
| Models, Organizational | 1 | 2015 | 545 | 0.390 |
Why?
|
| Data Collection | 3 | 2023 | 3315 | 0.370 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2380 | 0.360 |
Why?
|
| Intracranial Hemorrhages | 5 | 2023 | 844 | 0.350 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 16 | 0.340 |
Why?
|
| Internet | 7 | 2015 | 3078 | 0.330 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2013 | 1191 | 0.330 |
Why?
|
| Pandemics | 3 | 2022 | 8624 | 0.290 |
Why?
|
| Information Dissemination | 4 | 2021 | 1131 | 0.290 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 394 | 0.280 |
Why?
|
| Genetic Markers | 2 | 2004 | 2608 | 0.270 |
Why?
|
| Inpatients | 1 | 2018 | 2581 | 0.270 |
Why?
|
| Research Design | 2 | 2023 | 6180 | 0.260 |
Why?
|
| Bibliometrics | 2 | 2023 | 351 | 0.250 |
Why?
|
| User-Computer Interface | 3 | 2012 | 1403 | 0.240 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1500 | 0.230 |
Why?
|
| Research Personnel | 3 | 2021 | 582 | 0.230 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 3696 | 0.230 |
Why?
|
| Enoxaparin | 2 | 2017 | 397 | 0.220 |
Why?
|
| Faculty, Medical | 3 | 2017 | 1192 | 0.220 |
Why?
|
| Career Mobility | 2 | 2016 | 258 | 0.220 |
Why?
|
| Artificial Intelligence | 3 | 2018 | 2557 | 0.210 |
Why?
|
| Confidentiality | 3 | 2019 | 609 | 0.210 |
Why?
|
| Lymphatic System | 1 | 2024 | 254 | 0.200 |
Why?
|
| Genetics, Microbial | 1 | 2002 | 55 | 0.200 |
Why?
|
| Health Services Research | 1 | 2009 | 1810 | 0.190 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2176 | 0.190 |
Why?
|
| Brain Neoplasms | 5 | 2023 | 8986 | 0.190 |
Why?
|
| Information Systems | 2 | 2014 | 398 | 0.190 |
Why?
|
| Decision Making | 2 | 2013 | 3925 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2004 | 3775 | 0.180 |
Why?
|
| Humans | 64 | 2024 | 760621 | 0.180 |
Why?
|
| Venous Thromboembolism | 3 | 2018 | 1864 | 0.170 |
Why?
|
| Hospitalization | 6 | 2022 | 10790 | 0.170 |
Why?
|
| Computer Graphics | 1 | 2021 | 341 | 0.170 |
Why?
|
| Boston | 5 | 2018 | 9280 | 0.160 |
Why?
|
| Anticoagulants | 4 | 2022 | 4897 | 0.160 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 5325 | 0.160 |
Why?
|
| Phylogeny | 1 | 2005 | 2775 | 0.150 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 4625 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2021 | 791 | 0.150 |
Why?
|
| Computer Security | 2 | 2021 | 260 | 0.150 |
Why?
|
| Academic Medical Centers | 4 | 2017 | 2754 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4713 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1885 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4107 | 0.140 |
Why?
|
| Insurance Claim Reporting | 1 | 2017 | 165 | 0.140 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2018 | 345 | 0.140 |
Why?
|
| Disease | 1 | 2021 | 671 | 0.130 |
Why?
|
| Salicylates | 1 | 2016 | 127 | 0.130 |
Why?
|
| Physicians | 1 | 2013 | 4591 | 0.120 |
Why?
|
| Computational Biology | 3 | 2020 | 3505 | 0.120 |
Why?
|
| Financing, Government | 1 | 2017 | 472 | 0.110 |
Why?
|
| Programming Languages | 1 | 2014 | 128 | 0.110 |
Why?
|
| Intelligence | 2 | 2022 | 921 | 0.110 |
Why?
|
| Heart Failure | 1 | 2018 | 11847 | 0.110 |
Why?
|
| Medical Subject Headings | 1 | 2013 | 16 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1150 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 699 | 0.110 |
Why?
|
| Health Care Surveys | 2 | 2018 | 2435 | 0.110 |
Why?
|
| Retrospective Studies | 13 | 2023 | 80372 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2023 | 3201 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2021 | 786 | 0.100 |
Why?
|
| PubMed | 1 | 2013 | 128 | 0.100 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 116 | 0.100 |
Why?
|
| Information Services | 1 | 2014 | 235 | 0.100 |
Why?
|
| Publishing | 2 | 2021 | 836 | 0.100 |
Why?
|
| United States | 13 | 2021 | 72461 | 0.100 |
Why?
|
| Databases, Factual | 5 | 2021 | 8035 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2526 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1135 | 0.090 |
Why?
|
| Research | 2 | 2023 | 1974 | 0.090 |
Why?
|
| Databases, Genetic | 3 | 2009 | 1738 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12159 | 0.090 |
Why?
|
| Science | 1 | 2013 | 239 | 0.090 |
Why?
|
| Universities | 2 | 2014 | 992 | 0.090 |
Why?
|
| Fractures, Compression | 1 | 2011 | 129 | 0.080 |
Why?
|
| Hospital Administration | 1 | 2013 | 355 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3616 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 9411 | 0.080 |
Why?
|
| Public Policy | 1 | 2013 | 560 | 0.080 |
Why?
|
| Suicide | 1 | 2020 | 1599 | 0.080 |
Why?
|
| Genome, Human | 1 | 2002 | 4417 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1116 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 258 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 1 | 2009 | 204 | 0.080 |
Why?
|
| Medical Informatics | 2 | 2014 | 732 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20080 | 0.080 |
Why?
|
| Systems Integration | 1 | 2010 | 426 | 0.080 |
Why?
|
| Hospitals | 1 | 2021 | 3928 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 599 | 0.070 |
Why?
|
| Logistic Models | 1 | 2002 | 13314 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2009 | 580 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1535 | 0.060 |
Why?
|
| Genomics | 1 | 2021 | 5794 | 0.060 |
Why?
|
| Middle Aged | 13 | 2023 | 220352 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.060 |
Why?
|
| Expressed Sequence Tags | 2 | 2004 | 250 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 465 | 0.060 |
Why?
|
| Models, Theoretical | 3 | 2013 | 3562 | 0.060 |
Why?
|
| Overweight | 1 | 2016 | 2421 | 0.060 |
Why?
|
| Adult | 9 | 2023 | 219994 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1518 | 0.060 |
Why?
|
| Climacteric | 1 | 2004 | 57 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 1469 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1055 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 716 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2011 | 702 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2005 | 354 | 0.060 |
Why?
|
| ROC Curve | 2 | 2022 | 3568 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1416 | 0.060 |
Why?
|
| Phenotype | 1 | 2021 | 16546 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5251 | 0.050 |
Why?
|
| Diagnosis | 1 | 2004 | 157 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15840 | 0.050 |
Why?
|
| Informatics | 1 | 2023 | 73 | 0.050 |
Why?
|
| Logical Observation Identifiers Names and Codes | 1 | 2022 | 16 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3836 | 0.050 |
Why?
|
| Gene Library | 2 | 2004 | 1060 | 0.050 |
Why?
|
| Male | 13 | 2021 | 359744 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1167 | 0.050 |
Why?
|
| Female | 16 | 2021 | 391270 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 315 | 0.050 |
Why?
|
| Glioma | 1 | 2017 | 3420 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 1164 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 24123 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2020 | 2326 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13262 | 0.040 |
Why?
|
| Authorship | 1 | 2023 | 281 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2020 | 6796 | 0.040 |
Why?
|
| Subtraction Technique | 1 | 2003 | 510 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3242 | 0.040 |
Why?
|
| Neoplasms | 2 | 2015 | 22072 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 358 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 196 | 0.040 |
Why?
|
| Aged | 7 | 2023 | 169152 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2023 | 2698 | 0.040 |
Why?
|
| Communication | 1 | 2013 | 3849 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2008 | 1268 | 0.040 |
Why?
|
| Gene Expression | 2 | 2002 | 7588 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 749 | 0.040 |
Why?
|
| Obesity | 2 | 2023 | 12922 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2004 | 755 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8555 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 2049 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2002 | 658 | 0.040 |
Why?
|
| Viruses | 1 | 2002 | 376 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2021 | 340 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1075 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2012 | 9287 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2024 | 41335 | 0.040 |
Why?
|
| Government Regulation | 1 | 2021 | 525 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 10756 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1745 | 0.030 |
Why?
|
| Genome | 1 | 2004 | 1739 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2022 | 994 | 0.030 |
Why?
|
| Registries | 1 | 2012 | 8469 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 17624 | 0.030 |
Why?
|
| Prognosis | 4 | 2021 | 29658 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2005 | 3442 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14660 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3150 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2002 | 2194 | 0.030 |
Why?
|
| Base Sequence | 1 | 2005 | 12446 | 0.030 |
Why?
|
| San Francisco | 1 | 2014 | 162 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12965 | 0.030 |
Why?
|
| Retina | 1 | 2004 | 2635 | 0.030 |
Why?
|
| Organizations | 1 | 2014 | 171 | 0.030 |
Why?
|
| Vocabulary, Controlled | 1 | 2014 | 167 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 2017 | 359 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3604 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2022 | 10182 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2024 | 3486 | 0.030 |
Why?
|
| Efficiency | 1 | 2015 | 477 | 0.020 |
Why?
|
| Software Design | 1 | 2012 | 171 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2012 | 107 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2005 | 5075 | 0.020 |
Why?
|
| Mammography | 1 | 2002 | 2427 | 0.020 |
Why?
|
| Carcinoma | 1 | 2002 | 2331 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2017 | 878 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4035 | 0.020 |
Why?
|
| Aspirin | 1 | 2023 | 3364 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1650 | 0.020 |
Why?
|
| Online Systems | 1 | 2011 | 181 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2004 | 12766 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5889 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21392 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2515 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2015 | 1048 | 0.020 |
Why?
|
| Young Adult | 3 | 2023 | 58741 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12531 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58995 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9716 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 388 | 0.020 |
Why?
|
| Neurology | 1 | 2015 | 779 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 26181 | 0.020 |
Why?
|
| Adolescent | 3 | 2023 | 87810 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 597 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6544 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 707 | 0.020 |
Why?
|
| Systems Biology | 1 | 2009 | 482 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 74359 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12808 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36060 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2015 | 1116 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 21025 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2021 | 42063 | 0.010 |
Why?
|
| Time Factors | 3 | 2018 | 40165 | 0.010 |
Why?
|
| Macular Edema | 1 | 2008 | 374 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6315 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 311 | 0.010 |
Why?
|
| General Surgery | 1 | 2015 | 1678 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39261 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36290 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10547 | 0.010 |
Why?
|
| Child | 3 | 2021 | 79806 | 0.010 |
Why?
|
| Psychiatry | 1 | 2015 | 1689 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 13308 | 0.010 |
Why?
|
| Medical Records | 1 | 2008 | 1407 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12427 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 1109 | 0.010 |
Why?
|
| Radiology | 1 | 2015 | 2102 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 2002 | 4902 | 0.010 |
Why?
|
| Mathematics | 1 | 2002 | 707 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1341 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3334 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 814 | 0.010 |
Why?
|
| Markov Chains | 1 | 2004 | 968 | 0.010 |
Why?
|
| North America | 1 | 2004 | 1284 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1900 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11152 | 0.010 |
Why?
|
| Pediatrics | 1 | 2015 | 3586 | 0.010 |
Why?
|
| Animals | 3 | 2009 | 167963 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
| Interneurons | 1 | 2004 | 591 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 416 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1191 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2008 | 2643 | 0.010 |
Why?
|
| Neuroglia | 1 | 2004 | 944 | 0.010 |
Why?
|
| Disease Progression | 2 | 2008 | 13502 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2004 | 1724 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2421 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2004 | 1248 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10551 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22053 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15687 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1096 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2004 | 2001 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 3618 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6068 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 3455 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9467 | 0.010 |
Why?
|
| Mortality | 1 | 2004 | 2916 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 9631 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65017 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 14495 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 3523 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54303 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 11903 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4024 | 0.000 |
Why?
|
| Mass Screening | 1 | 2002 | 5423 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 9073 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 12293 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 81208 | 0.000 |
Why?
|